0001209191-20-054142.txt : 20201007
0001209191-20-054142.hdr.sgml : 20201007
20201007165014
ACCESSION NUMBER: 0001209191-20-054142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201001
FILED AS OF DATE: 20201007
DATE AS OF CHANGE: 20201007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reilly Thomas Charles
CENTRAL INDEX KEY: 0001827590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36279
FILM NUMBER: 201229506
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001346830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-406-3700
MAIL ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: Cara Therapeutics Inc
DATE OF NAME CHANGE: 20051213
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-01
0
0001346830
Cara Therapeutics, Inc.
CARA
0001827590
Reilly Thomas Charles
C/O CARA THERAPEUTICS, INC.
4 STAMFORD PLAZA, 107 ELM STREET
STAMFORD
CT
06902
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
12.74
2020-10-01
4
A
0
175000
0.00
A
2030-10-01
Common Stock
175000
175000
D
25% of the shares vest and become exercisable on October 1, 2021; the balance of the shares vest and become exercisable in a series of 36 successive equal monthly installments at the end of each calendar month thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such date.
/s/ Alison Haggerty, Attorney-in-Fact
2020-10-07